Prednisolone Acetate Ophthalmic suspension USP is a prescription medication which is indicated for use in people with cornea, bulbar and palpebral conjunctiva, and anterior segment of the globe including acne rosacea, allergic conjunctivitis, iritis, herpes zoster keratitis, and some types of infective conjunetivitides.
Prednisolone suspension is an adrenocortical steroid product made as a sterile ophthalmic suspension. In case inflammation or pain which occurs longer than 2 days or becomes worse, you should consult your physician right away. Only your doctor may decide if this suspension is safe for you or whether or not you should continue or discontinue its use.
Prednisolone Acetate ophthalmic suspension is sterile when packaged. To avoid contamination, you should not touch the bottle tip to eyelids or to any other surface. The use of the bottle with more than one individual may spread infection. You should keep this medication tightly closed when not in use. Breastfeeding women should not use this medication, because it may appear in breast milk and affect a nursing baby.
You should consult your doctor, when you are pregnant or breastfeeding before using prednisolone products. Safety and effectiveness in children are unknown. Side effects such as elevation of intraocular pressure with possible development of glaucoma and optic nerve damage, delayed wound healing and posterior subcapsular cataract formation may occur, while using this suspension.
Usual dosage of prednisolone acetate ophthalmic is 2 drops in one or two eyes 4 times per day. In case of bacterial infections, use of anti-infective medications is required. The dosage of prednisolone ophthalmic depends on severity of the disease and may be increased or decreased by your doctor. In chronic cases, withdrawal of treatment must be carried out by gradually decreasing the frequency of this drug. Keep out of reach of children.